ArticleOncotarget2017

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Shogo Hosogoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.